BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36927132)

  • 1. Directional atherectomy combined with drug-coated balloon angioplasty for superficial femoral arteriosclerosis obliterans.
    Su Z; Li Y; Wang C; Guo J; Guo L; Gu Y
    Ann R Coll Surg Engl; 2023 Sep; 105(7):627-631. PubMed ID: 36927132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of femoropopliteal arteriosclerosis obliterans.
    Su Z; Li Y; Yang S; Guo J; Guo L; Gu Y
    Ann R Coll Surg Engl; 2022 Nov; 104(9):667-672. PubMed ID: 35446161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans.
    Cai Z; Guo L; Qi L; Cui S; Tong Z; Guo J; Wang Z; Gu Y
    Ann Vasc Surg; 2020 Apr; 64():181-187. PubMed ID: 31449956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
    Stavroulakis K; Schwindt A; Torsello G; Beropoulis E; Stachmann A; Hericks C; Bollenberg L; Bisdas T
    J Endovasc Ther; 2018 Feb; 25(1):92-99. PubMed ID: 29251204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
    Rodoplu O; Oztas DM; Meric M; Beyaz MO; Ulukan MO; Yildiz CE; Unal O; Ugurlucan M
    Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
    Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early outcomes of novel Temren atherectomy device combined with drug-coated balloon angioplasty for treatment of femoropopliteal lesions.
    Yiğit G
    Vascular; 2022 Aug; 30(4):739-748. PubMed ID: 34180304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directional atherectomy and drug-coated balloon angioplasty vs. bare nitinol stent angioplasty for femoropopliteal artery lesions.
    Wei L; Guo J; Guo L; Qi L; Cui S; Tong Z; Hou P; Gu Y
    Vasa; 2022 Sep; 51(5):275-281. PubMed ID: 35801303
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM; Hyder ON; Soukas PA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries.
    Sixt S; Carpio Cancino OG; Treszl A; Beschorner U; Macharzina R; Rastan A; Krankenberg H; Neumann FJ; Zeller T
    J Vasc Surg; 2013 Sep; 58(3):682-6. PubMed ID: 23755977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-Year Clinical Outcome and Risk Factor Analysis of Directional Atherectomy Followed With Drug-Coated Balloon for Femoropopliteal Artery Disease.
    Feng Z; Yang S; Sang H; Xue G; Ni Q; Zhang L; Zhang W; Fang X; Ye M
    J Endovasc Ther; 2021 Dec; 28(6):927-937. PubMed ID: 34251279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography guided directional atherectomy with antirestenotic therapy for femoropopliteal arterial disease.
    Stavroulakis K; Bisdas T; Torsello G; Argyriou A; Bollenberg L; Schwindt A
    J Cardiovasc Surg (Torino); 2019 Apr; 60(2):191-197. PubMed ID: 30665284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.
    Zeller T; Langhoff R; Rocha-Singh KJ; Jaff MR; Blessing E; Amann-Vesti B; Krzanowski M; Peeters P; Scheinert D; Torsello G; Sixt S; Tepe G;
    Circ Cardiovasc Interv; 2017 Sep; 10(9):e004848. PubMed ID: 28916599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions.
    Kokkinidis DG; Jawaid O; Cantu D; Martinsen BJ; Igyarto Z; Valle JA; Waldo SW; Armstrong EJ
    J Endovasc Ther; 2020 Jun; 27(3):492-501. PubMed ID: 32364000
    [No Abstract]   [Full Text] [Related]  

  • 18. Rotational Atherectomy Plus Drug-Coated Balloon Angioplasty for the Treatment of Total In-Stent Occlusions in Iliac and Infrainguinal Arteries.
    Milnerowicz A; Milnerowicz A; Kuliczkowski W; Protasiewicz M
    J Endovasc Ther; 2019 Jun; 26(3):316-321. PubMed ID: 30907258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoablative atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis in instent femoro-popliteal obstructions (PHOTOPAC).
    Böhme T; Noory E; Beschorner U; Lerke F; Schmidt A; Scheinert D; Ito W; Zeller T; Rastan A
    Vasa; 2021 Sep; 50(5):387-393. PubMed ID: 34107772
    [No Abstract]   [Full Text] [Related]  

  • 20. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.